Gilde Healthcare

Gilde Healthcare, headquartered in Utrecht, Netherlands, with offices in Boston and Frankfurt, is a leading European venture capital firm specializing in healthcare investments. Gilde manages €2.6 billion across its Venture&Growth and Private Equity funds. The Venture&Growth fund focuses on healthtech and therapeutics, investing in early revenue or clinical stage companies in Europe and North America, with notable investments in companies like Lava Therapeutics and CVRx. Their typical equity investments reach up to €50 million, often taking significant minority stakes. The Private Equity fund targets profitable mid-market European healthcare providers and medical product suppliers, including investments like Symeres and Acti-Med​. The firm's strategy emphasizes improving care at lower costs, supported by an expert team of industry veterans, scientists, and entrepreneurs who offer hands-on growth strategy support. Gilde prefers to lead investment rounds and is particularly active in sectors like drug delivery and digital health. For startups seeking investment, it's beneficial to approach Gilde with a strong value proposition in healthtech or therapeutics, demonstrating clear potential for cost-effective healthcare improvements. Key team members include co-founders Edwin de Graaf and Pieter Van der Meer, who bring decades of industry expertise to their leadership roles​.